In conclusion, the key findings of the current study highlight the therapeutic value of MIF in the treatment of PR-M-positive uterine leiomyoma, which results in the autophagy and apoptosis of cancer cells by regulating Bcl-2/Beclin1 axis (Figure 7). The gene discussed is BECN1; the disease is Uterine leiomyoma.